There was less treatment failure among patients from the methylprednisolone group ( 8 patients [ 13 % ] ) compared with the placebo group ( 18 patients [ 31 % ] ) ( P = .02 ) , with a difference between groups of 18 % ( 95 % CI , 3 % to 32 % ) .